ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY Trademark Information

DAIICHI SANKYO COMPANY, LIMITED

Pharmaceutical preparations for the treatment of cardiovascular diseases, circulatory diseases, urinary diseases, metabolic diseases, diabetic nephropathy and stroke

Pharmaceutical and scientific research, namely, conducting clinical studies, trials and investigations

This is a brand page for the ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark by DAIICHI SANKYO COMPANY, LIMITED  in , , .

Write a review about a product or service associated with this ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark. Or, contact the owner DAIICHI SANKYO COMPANY, LIMITED of the ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark.

On Wednesday, May 19, 2004, a U.S. federal trademark registration was filed for ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY. The USPTO has given the ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark serial number of 79003305. The current federal status of this trademark filing is IR CANCELLED; US REGISTRATION CANCELLED. The correspondent listed for ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY is WENPING & CO. of 8th Fl., Wenping Kanda Bldg.,, 6-7, Kanda Kajicho 3-chome,, Chiyoda-ku Tokyo 101-0045, Japan . The ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark is filed in the category of Pharmaceutical Products , Computer & Software Services & Scientific Services . The description provided to the USPTO for ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY is Pharmaceutical preparations for the treatment of cardiovascular diseases, circulatory diseases, urinary diseases, metabolic diseases, diabetic nephropathy and stroke.

Word mark: ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY
Status/Status Date:
IR CANCELLED; US REGISTRATION CANCELLED
5/20/2014
Serial Number: 79003305
Filing Date: 5/19/2004
Registration Number: 3035932
Registration Date: 12/27/2005
Goods and Services: Pharmaceutical preparations for the treatment of cardiovascular diseases, circulatory diseases, urinary diseases, metabolic diseases, diabetic nephropathy and stroke
Mark Description: The design portion of the mark consists of a stylized world globe.
Type Of Mark: Service Mark
Published For Opposition Date: 10/4/2005
Last Applicant/Owner: DAIICHI SANKYO COMPANY, LIMITED
Mark Drawing Code: Drawing/Design + Words
Design Search:
Globes with outlines of continents (Celestial bodies, Natural phenomena, Geographical maps - Globes) see more design...
Other arrows (Heraldry, flags, crowns, crosses, arrows and symbols - Arrows) see more design...
Rectangles that are completely or partially shaded (Geometric figures and solids - Rectangles) see more design...
Register Type: Principal
Disclaimer: ("randomized olmesartan and diabetes microalbuminuria prevention study")
Correspondent:
8th Fl., Wenping Kanda Bldg.,
6-7, Kanda Kajicho 3-chome,
Chiyoda-ku
Tokyo 101-0045, Japan

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Current Trademark Status:
5/20/2014
IR CANCELLED; US REGISTRATION CANCELLED
Correspondent Search:

WENPING & CO. is a correspondent of ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!